Drug Approval | March 28, 2024
Briefs: Alkem Laboratories and Zydus Lifesciences
USFDA inspects Zydus Lifesciences’ Ahmedabad SEZ Onco manufacturing plant
USFDA inspects Zydus Lifesciences’ Ahmedabad SEZ Onco manufacturing plant
The inspection at Unit 1 by the USFDA has been successfully completed, with no observations under Form 483
The company will provide comprehensive response to USFDA for the observations
Cipla completes transfer of Generics Business Undertaking
Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully
Laurus Synthesis receives Form 483 with 5 observations from USFDA
Dr. Reddy's Laboratories has been issued a Form 483 with three observations
The company has received Form 483 with three observations
Balaxi Healthcare Ecuador S.A.S. has become a Wholly Owned Subsidiary of the company
Mankind Pharma commences the commercial operations newly set-up plant in Udaipur
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
